Advertisement

The FDA clears AFrame’s MobileCare monitor as Class II device for the U.S. market.

AFrame Digital logo

Reston, Va.-based company AFrame Digital landed FDA clearance to market its MobileCare Monitor as a Class II medical device, which has had Class I approval since 2009, according to the press release.

The wristwatch-based health monitor can measure patient gait and provide real-time data, generating an alert to designated caregivers via a smartphone or other mobile device, the company said.

Advertisement
Advertisement